Waiver of Jury Trial Clause Example from Business Contracts

Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

Sales Agreement, dated February 26, 2019, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 26, 2019)

Sales Agreement, dated February 27, 2020, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on February 27, 2020)

Sales Agreement, dated November 26, 2021, by and between Atara Biotherapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 26, 2021)

ATARA BIOTHERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on March 27, 2017)

Sales Agreement, dated as of March 12, 2019, between Krystal Biotech, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

Sales Agreement, dated December 31, 2020, by and between Krystal Biotech, Inc. and Cowen and Company, LLC (Filed With SEC on December 31, 2020)

Sales Agreement, dated as of March 29, 2019, by and between Immunomedics, Inc. and Cowen and Company, LLC (Filed With SEC on March 29, 2019)

Sales Agreement dated August 13, 2019, by and between Boston Omaha Corporation and Cowen and Company, LLC (Filed With SEC on August 13, 2019)

Sales Agreement dated March 2, 2018, by and between Boston Omaha Corporation and Cowen and Company, LLC (Filed With SEC on March 2, 2018)

Sales Agreement, dated as of September 10, 2019, by and between Tilray and Cowen and Company, LLC (Filed With SEC on September 10, 2019)

Sales Agreement, dated as of November 27, 2019, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on November 27, 2019)

Sales Agreement, dated as of March 18, 2020, between Seres Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on March 18, 2020)

Sales Agreement dated January 3, 2020 by and between MyoKardia, Inc. and Cowen and Company, LLC (Filed With SEC on January 3, 2020)

Sales Agreement, dated July 31, 2020, by and between Unity Biotechnology, Inc. and Cowen and Company, LLC (Filed With SEC on July 31, 2020)

Sales Agreement, dated August 6, 2020, between the Company and Cowen and Company, LLC (Filed With SEC on August 6, 2020)

Sales Agreement, dated as of November 10, 2020, by and between DermTech, Inc. and Cowen and Company, LLC (Filed With SEC on November 10, 2020)

Common Stock Sales Agreement, dated December 17, 2020 (Filed With SEC on December 17, 2020)

Sales Agreement, dated July 2, 2021, between Avidity Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on July 2, 2021)

Sales Agreement, dated November 8, 2022, between Avidity Biosciences, Inc. and Cowen and Company, LLC (Filed With SEC on November 8, 2022)

Sales Agreement, dated August 2, 2021, by and among Greenlane Holdings, Inc. and Cowen and Company, LLC (Filed With SEC on August 2, 2021)

Sales Agreement, dated as of August 16, 2021, by and between Annexon Inc. and Cowen and Company, LLC (Filed With SEC on August 16, 2021)

Sales Agreement, by and among Aptinyx Inc. and Cowen and Company, LLC, dated September 16, 2021 (Filed With SEC on September 16, 2021)

Sales Agreement, dated October 22, 2021, by and between DarioHealth Corp. and Cowen and Company, LLC (Filed With SEC on October 22, 2021)

Sales Agreement by and between the Registrant and Cowen and Company, LLC, dated as of February 23, 2022 (Filed With SEC on February 23, 2022)

Sales Agreement dated February 28, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on February 28, 2022)

Sales Agreement dated November 7, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on November 7, 2022)

Sales Agreement, dated February 28, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 1, 2022)

Sales Agreement dated as of March 17, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 17, 2022)

Sales Agreement, between the Company and Cowen and Company, LLC, dated as of August 4, 2022 (Filed With SEC on August 5, 2022)

Sales Agreement, dated as of August 9, 2022, between Quotient Limited and Cowen and Company, LLC (Filed With SEC on August 9, 2022)

Sales Agreement, dated February 15, 2023 by and between IO Biotech, Inc. and Cowen and Company, LLC (Filed With SEC on February 15, 2023)

Sales Agreement dated March 24, 2023 (Filed With SEC on March 24, 2023)

Sales Agreement, dated November 8, 2018, between Chiasma, Inc. and Cowen and Company, LLC (Filed With SEC on November 8, 2018)

Sales Agreement dated November 9, 2018 by and between Zafgen, Inc. and Cowen and Company, LLC (Filed With SEC on November 9, 2018)

Sales Agreement, dated as of November 13, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on November 13, 2018)

CATABASIS PHARMACEUTICALS, INC. $10,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on August 11, 2016)

Sales Agreement, dated August 31, 2018 by and between VirnetX Holding Corporation and Cowen and Company, LLC (Filed With SEC on August 31, 2018)

Sales Agreement dated August 31, 2018 by and between Corindus Vascular Robotics, Inc. and Cowen and Company, LLC (Filed With SEC on August 31, 2018)

Common Stock Sales Agreement, dated June 15, 2018, by and between Trevena, Inc. and Cowen and Company, LLC (Filed With SEC on June 15, 2018)

TREVENA, INC. UP TO $40,000,000 OF SHARES COMMON STOCK SALES AGREEMENT (Filed With SEC on April 3, 2015)

TREVENA, INC. UP TO $75,000,000 OF SHARES COMMON STOCK SALES AGREEMENT (Filed With SEC on December 14, 2015)

Sales Agreement, dated as of June 22, 2018, between Axovant Sciences Ltd. and Cowen and Company, LLC (Filed With SEC on June 22, 2018)

Sales Agreement, dated as of April 2, 2018, between Myovant Sciences Ltd. and Cowen and Company, LLC (Filed With SEC on April 3, 2018)

Amended and Restated Sales Agreement, dated as of February 2, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on February 5, 2018)

Common Stock Sales Agreement, dated February 27, 2018, by and between the Company and Cowen and Company, LLC (Filed With SEC on February 27, 2018)

Amended and Restated Sales Agreement, dated March 12, 2018, by and between Kura Oncology, Inc. and Cowen and Company, LLC (Filed With SEC on March 12, 2018)

KURA ONCOLOGY, INC. $25,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on January 27, 2017)

Sales Agreement, dated March 30, 2018, by and between Senseonics Holdings, Inc. and Cowen and Company, LLC (Filed With SEC on March 30, 2018)

MIRAGEN THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)

SANGAMO BIOSCIENCES, INC. AT-THE-MARKET OFFERING PROGRAM SALES AGREEMENT (Filed With SEC on December 7, 2016)

AMICUS THERAPEUTICS, INC. $100,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on February 26, 2016)

AMICUS THERAPEUTICS, INC. $40,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on March 4, 2014)

GLYCOMIMETICS, INC. common Stock (par value $0.001 per share) SALES AGREEMENT (Filed With SEC on March 1, 2016)

OPGEN, INC. $25,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on September 14, 2016)

KEMPHARM, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on October 3, 2016)

ONCOTHYREON INC. $50,000,000 SALESAGREEMENT (Filed With SEC on June 2, 2016)

TONIXPHARMACEUTICALS HOLDING CORP. $15,000,000 COMMONSTOCK SALESAGREEMENT (Filed With SEC on April 28, 2016)

COHERUS BIOSCIENCES, INC. $100,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on October 28, 2016)

ULTRAGENYX PHARMACEUTICAL INC. $150,000,000 SALESAGREEMENT (Filed With SEC on July 5, 2016)

CONTRAFECT CORPORATION UP TO $30,000,000 OF SHARES OF COMMON STOCK SALES AGREEMENT (Filed With SEC on January 20, 2016)

CEMPRA, INC. $150,000,000 SALESAGREEMENT (Filed With SEC on May 6, 2016)

REVANCE THERAPEUTICS, INC. $75,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on March 7, 2016)

ACLARIS THERAPEUTICS, INC. $75,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on November 2, 2016)

PIERIS PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on October 5, 2016)

VERICEL CORPORATION $25,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on October 11, 2016)

CYTORI THERAPEUTICS, INC. $40,000,000 SALESAGREEMENT (Filed With SEC on May 12, 2014)

ENTEROMEDICS INC. $25,000,000 SALESAGREEMENT (Filed With SEC on June 13, 2014)

AMERICAN APPAREL, INC. $10,000,000 AGGREGATE SALES PRICE OF COMMON STOCK SALES AGREEMENT (Filed With SEC on May 11, 2015)

PROTEON THERAPEUTICS,INC. $40,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on November 12, 2015)

MAST THERAPEUTICS, INC. $30,000,000 SALESAGREEMENT (Filed With SEC on August 21, 2015)

INTRA-CELLULAR THERAPIES, INC. AT-THE-MARKET OFFERING PROGRAM $50,000,000 SALESAGREEMENT (Filed With SEC on May 28, 2015)

XOMA CORPORATION $75,000,000 SALESAGREEMENT (Filed With SEC on November 12, 2015)

SYNTA PHARMACEUTICALS CORP. $100,000,000 SALES AGREEMENT (Filed With SEC on October 16, 2015)